Getting information about the FDA and its activities - FDA Contacts - Brief Article
More FDA approvalsDrugs in Development (Not yet approved) Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial... More drugs in developmentDrug Information A to Z Drug List Treatment Options Drugs by ...
FDA Guidance documents relevant to Pharmacology and Toxicology information are available and describe ways in which requirements related to conduct of non-clinical toxicology studies may be met. In addition to description of th...
FDA Guidance documents relevant to Pharmacology and Toxicology information are available and describe ways in which requirements related to conduct of non-clinical toxicology studies may be met. In addition to description of ...
Access comprehensive, FDA-approved prescribing information, including detailed clinical pharmacology data for over 5,000 medications.
"The FDA is saddened to hear of the passing of a consumer and as always, takes seriously reports of illnesses or injury from regulated products," the agency said in a statement to CBS News. "At this point, we are gathering information about this event," the agency added. "The agency mo...
Over the counter medication labels and full package insert information directly from the approved FDA repository, by OTCLabels.com.
Read about lawsuit updates and news linked to drugs, medical devices and consumer products. Read more news here Defective Medical Devices Philips Agrees to Stop Selling CPAP Machines as Part of Settlement Deal Dangerous Drugs AstraZeneca Agrees to $425 Million for PPI Lawsuits[...] ...
Everyday Health inspires and empowers people to live their healthiest lives, every day, through trusted, medically reviewed information and expert health advice from the nation's leading healthcare providers and patient advocates. Learn more about health
与药理学和毒理学信息相关的FDA指导性文件可以在官网获得,并描述了可以满足非临床毒理学研究有关的要求的方法。除了描述每项研究的结果外,IND申请人被要求还需要包括评估每项研究结果并得出结论的负责人的身份和职位等信息,且此负责人认为拟议的研究是合理安全的。